Education
About Us
Working with TipRanks
Follow Us
Marpai (MRAI)
OTHER OTC:MRAI
Earnings Data
Report Date
May 07, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
―Last Year’s EPS
-0.65Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 26, 2025
|% Change Since: -11.20%
|Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant operational improvements and strategic initiatives aimed at reducing costs and enhancing profitability, showing a strong commitment to shareholder value. However, challenges such as revenue decline and a low cash position temper the positive outlook.Company Guidance
During Marpai's fourth quarter and full-year 2024 earnings call, the company provided guidance focusing on achieving profitability by 2025, driven by strategic initiatives in revenue growth and customer experience. The call emphasized the launch of MarpaiRx in the second half of 2025, expected to reduce prescription costs and drive revenue growth. Marpai's financial highlights included reducing their operating loss from $3.1 million to $2.7 million and improving net loss from $2.4 million in Q3 to $1.2 million in Q4. Earnings per share improved by $0.22 from Q3, ending at a loss of $0.08. The adjusted EBITDA loss for 2024 was $9.1 million, significantly improved from the previous year's $20.2 million. The company also highlighted operational improvements, such as reducing average speed to answer calls to less than 10 seconds and claims processing turnaround to seven business days. With a cash position of $800,000 at year-end, Marpai secured an additional $5 million from JGB Capital to support growth until cash flow positivity is achieved in 2025.Significant Reduction in Losses
Reduced operating loss from approximately $3.1 million to $2.7 million in Q4, with net loss down to $1.2 million from $2.4 million in Q3. Improved earnings per share by $0.22 from Q3 to a loss of $0.08.
Adjusted EBITDA Improvement
Adjusted EBITDA loss for 2024 was $9.1 million, a significant improvement from the $20.2 million loss in 2023, showing effective resource utilization and expense reduction.
Strategic Initiatives for Growth
Investment in new services like Empara member engagement and MarpaiRx, aiming for high growth and profitability in 2025 with a focus on revenue growth, customer experience, and cost savings.
Operational Efficiency Enhancements
Reduced average speed to answer calls to less than 10 seconds and claims processing turnaround to seven business days, leveraging AI for operational improvements.
---
MRAI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MRAI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 26, 2025 | $1.25 | $0.99 | -20.80% |
| Nov 11, 2024 | $0.77 | $1.05 | +36.36% |
| Aug 07, 2024 | $0.51 | $0.60 | +17.65% |
| May 09, 2024 | $2.38 | $2.24 | -5.88% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Marpai (MRAI) report earnings?
Marpai (MRAI) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
What is Marpai (MRAI) earnings time?
Marpai (MRAI) earnings time is at May 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MRAI EPS forecast?
Currently, no data Available
---